Seagen
SGEN
#592
Rank
NZ$73.85 B
Marketcap
NZ$391.44
Share price
-0.07%
Change (1 day)
73.29%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -NZ$1.29 Billion

According to Seagen 's latest financial reports the company's current earnings are NZ$2.30 Billion. In 2022 the company made an earning of -NZ$1.05 Billion, an increase over its 2021 earnings that were of -NZ$1.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$1.29 Billion22.3%
2022 -NZ$1.05 Billion-10.13%
2021 -NZ$1.17 Billion-214.28%
2020 NZ$1.02 B-370.63%
2019 -NZ$0.38 Billion-15.17%
2018 -NZ$0.45 Billion32.79%
2017 -NZ$0.34 Billion37.19%
2016 -NZ$0.25 Billion18%
2015 -NZ$0.21 Billion56.34%
2014 -NZ$0.14 Billion23.07%
2013 -NZ$0.11 Billion
2011 -NZ$0.25 Billion111.72%
2010 -NZ$0.12 Billion-19.63%
2009 -NZ$0.15 Billion-7.55%
2008 -NZ$0.16 Billion64.95%
2007 -NZ$95.23 Million38.4%
2006 -NZ$68.81 Million25.36%
2005 -NZ$54.89 Million-14.86%
2004 -NZ$64.47 Million61.92%
2003 -NZ$39.82 Million-7.67%
2002 -NZ$43.12 Million6.76%
2001 -NZ$40.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.12 B-1,439.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.28 B-934.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.77 B-305.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.42 B-1,313.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.13 B-1,366.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-NZ$0.11 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.5 Billion-63.65%๐Ÿ‡บ๐Ÿ‡ธ USA